{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-000366","form_type":"8-K","ticker":"COR","cik":"0001140859","company_name":"Cencora, Inc.","filed_at":"2025-01-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.029364+00:00","generated_at":"2026-05-28T17:37:29.607891+00:00","sec_items":["2.01","7.01","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Cencora completes $4.4B acquisition of Retina Consultants of America; raises FY2025 adjusted EPS guidance","bullets":["Cencora acquires ~85% interest in Retina Consultants of America for $4.4B cash outlay, with post-closing adjustment.","RCA becomes Cencora subsidiary; certain RCA physicians and management retain minority equity interest.","FY2025 adjusted diluted EPS guidance raised to $15.15-$15.45 from prior $14.80-$15.10, reflecting RCA contribution and momentum.","Acquisition expands Cencora's specialty leadership, MSO solutions, and value for physicians and patients."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-000366","json":"https://secwatch.observer/filing/0001104659-25-000366.json","markdown":"https://secwatch.observer/filing/0001104659-25-000366.md","text":"https://secwatch.observer/filing/0001104659-25-000366.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1140859/000110465925000366/0001104659-25-000366-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1140859/000110465925000366/tm2432308d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-28T17:37:29.607891+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"b08549a31cb0f98375bb78f211cdce9467a14a1e","claim":"Cencora, Inc. completed an acquisition involving Webster Equity Partners (seller) / Retina Midco, Inc. (\"Retina Consultants of America\" or \"RCA\") for $4.4 billion (closed 2025-01-02).","evidence_excerpt":"in RCA of approximately 85%, with certain RCA physicians and members of the management team retaining a minority equity interest in RCA. The Company’s cash outlay at closing was $4.4 billion, which amount is subject to a customary post-closing purchase price adjustment. --- EX-99.1 (EXHIBIT 99.1) --- EX-99.1 2 tm2432308d1_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Press","evidence_source":"SEC 8-K Item 2.01/5.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1140859/000110465925000366/0001104659-25-000366-index.htm","confidence":0.9,"family_label":"M&A Transactions","details":[{"label":"Action","value":"acquisition"},{"label":"Counterparty","value":"Webster Equity Partners (seller) / Retina Midco, Inc. (\"Retina Consultants of America\" or \"RCA\")"},{"label":"Consideration","value":"$4.4 billion"},{"label":"Closing","value":"2025-01-02"}],"fact_type":"ma_transaction"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}